SoftBank Pitcher Hsu Ru-Hsi's Recovery Ahead of Schedule, Japanese Media Reports September Return
Translated from Chinese, summarized and contextualized by DistantNews.
At a glance
- Taiwanese pitcher Hsu Ru-Hsi, who plays for SoftBank, is recovering from lumbar disc herniation surgery.
- Japanese media reports, citing SoftBank pitching coach Shinji Kurano, suggest Hsu could return to action as early as September.
- Hsu has shown a surprisingly fast recovery, having already engaged in throwing sessions and bullpen practice.
Taiwanese pitcher Hsu Ru-Hsi, currently on the injured list for the SoftBank Hawks after undergoing surgery for lumbar disc herniation, is demonstrating a remarkably swift recovery. Japanese sports media, in consultation with SoftBank's pitching chief coach Shinji Kurano, indicates that Hsu could potentially make a comeback to competitive play as early as September.
Hsu was observed at Fukuoka's PayPay Dome on August 24, showcasing strong throwing and catching abilities. Prior to this, on August 22, he participated in bullpen sessions where a catcher received his pitches in a semi-crouched position. Coach Kurano confirmed that further bullpen sessions with a catcher in a full squat are planned.
"Based on his current progress, I believe he will definitely be able to return to actual games within September," Kurano stated. Hsu underwent surgery on July 15 in Amagasaki City, Hyogo Prefecture. While the initial recovery timeline was estimated at two to three months, his current pace has exceeded expectations.
This season, Hsu has appeared in six games, recording a win-loss record of 2-3 with an earned run average of 4.99. His accelerated recovery suggests a strong determination to return to the mound and contribute to the SoftBank Hawks' season.
Based on his current progress, I believe he will definitely be able to return to actual games within September.
Originally published by Liberty Times in Chinese. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.